A fluorogenic substrate for the detection of lipid amidases in intact cells

Abstract

Lipid amidases of therapeutic relevance include acid ceramidase (AC), N-acylethanolamine-hydrolyzing acid amidase, and fatty acid amide hydrolase (FAAH). Although fluorogenic substrates have been developed for the three enzymes and high-throughput methods for screening have been reported, a platform for the specific detection of these enzyme activities in intact cells is lacking. In this article, we report on the coumarinic 1-deoxydihydroceramide RBM1-151, a 1-deoxy derivative and vinilog of RBM14-C12, as a novel substrate of amidases. This compound is hydrolyzed by AC (^appK_m = 7.0 μM; ^appV_max = 99.3 nM/min), N-acylethanolamine-hydrolyzing acid amidase (^appK_m = 0.73 μM; ^appV_max = 0.24 nM/min), and FAAH (^appK_m = 3.6 μM; ^appV_max = 7.6 nM/min) but not by other ceramidases. We provide proof of concept that the use of RBM1-151 in combination with reported irreversible inhibitors of AC and FAAH allows the determination in parallel of the three amidase activities in single experiments in intact cells.

Keywords: N-acylethanolamine acid amidase; N-palmitoylethanolamine; anandamide; ceramidases; ceramides; chemical synthesis; enzymology; fatty acid amide hydrolase; lipids; sphingolipids.